Skip to main content

Waystar Holding Corp. (WAY) Stock Analysis

Falling Knife setup

HoldModerate Confidence

Healthcare · Health Information Services

Hold if already holding. Not a fresh buy at $20.00, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -6.9%/30d (confirmed downtrend).

Waystar provides cloud-based, AI-powered healthcare payments software to 30,000+ clients representing 1+ million providers, processing 7.5 billion transactions ($2.4T in annual gross claims) for revenue cycle management, eligibility, prior auth, denials, and patient payments.... Read more

$20.00+59.5% A.UpsideScore 6.5/10#1 of 13 Health Information Services
QualityF-score9 / 9FCF yield9.21%
Stop $18.23Target $31.27(analyst − 10%)A.R:R 4.1:1
Analyst target$34.74+73.7%23 analysts
$31.27our TP
$20.00price
$34.74mean
$44

Hold if already holding. Not a fresh buy at $20.00, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -6.9%/30d (confirmed downtrend). Chart setup: Death cross, below all MAs, RSI 27, MACD bearish. Maintain position. Not compelling to add more. Score 6.5/10, moderate confidence.

Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 71d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

Recent Developments — Waystar Holding Corp.

Generated 2026-05-20T20:21:22Z.

Thesis

Rewards
V7 quality resilience bonus: +0.2 (Q=7.0 in RISK_OFF)
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Risks
Negative momentum
Below 200-MA, MA slope -6.9%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)27.7
P/E (Fwd)10.1
Mkt Cap$3.6B
EV/EBITDA11.8
Profit Mgn10.9%
ROE3.6%
Rev Growth22.4%
Beta
DividendNone
Rating analysts28

Quality Signals

Piotroski F9/9MoatNarrow

Options Flow

P/C3.25bearish
IV64%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker·2 ceiling hits

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Ma Position
1.0
Rsi
3.0
Volume
3.9
Obv
10.0
Capitulation risk (RSI 27, below 200MA)Volume accumulation (rising OBV)Below 200-MA, MA slope -6.9%/30d — confirmed downtrend
GatesMomentum 3.6<4.5Death cross (50MA < 200MA)A.R:R 4.1 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 71d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Aggressive
RSI
27 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $17.89Resistance $26.32

Price Targets

$18
$31
A.Upside+56.4%
A.R:R4.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Momentum score 3.6/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (71d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is WAY stock a buy right now?

Hold if already holding. Not a fresh buy at $20.00, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -6.9%/30d (confirmed downtrend). Chart setup: Death cross, below all MAs, RSI 27, MACD bearish. Maintain position. Not compelling to add more. Target $31.27 (+56.4%), stop $18.23 (−9.7%), A.R:R 4.1:1. Score 6.5/10, moderate confidence.

What is the WAY stock price target?

Take-profit target: $31.27 (+59.5% upside). Target $31.27 (+56.4%), stop $18.23 (−9.7%), A.R:R 4.1:1. Stop-loss: $18.23.

What are the risks of investing in WAY?

Negative momentum; Below 200-MA, MA slope -6.9%/30d (confirmed downtrend).

Is WAY overvalued or undervalued?

Waystar Holding Corp. trades at a P/E of 27.7 (forward 10.1). TrendMatrix value score: 8.0/10. Verdict: Hold.

What do analysts say about WAY?

28 analysts cover WAY with a consensus score of 4.2/5. Average price target: $35.

What does Waystar Holding Corp. do?Waystar provides cloud-based, AI-powered healthcare payments software to 30,000+ clients representing 1+ million...

Waystar provides cloud-based, AI-powered healthcare payments software to 30,000+ clients representing 1+ million providers, processing 7.5 billion transactions ($2.4T in annual gross claims) for revenue cycle management, eligibility, prior auth, denials, and patient payments. Revenue is subscription-based with SaaS fees and transaction-based charges; the top 10 clients represent only 10.8% of total revenue.

Related stocks: VEEV (Veeva Systems Inc.) · HNGE (Hinge Health, Inc.) · HQY (HealthEquity, Inc.) · PRVA (Privia Health Group, Inc.) · MMED (MiniMed Group, Inc.)